Study on the Efficacy of MDK Targeting Hepatocellular Carcinoma (HCC) in Enhancing Anti-PD-1 Immunotherapy

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 3d920ba60f0887291f65ea74c4a9184e84b6a023
First added on: Oct 10, 2026